Cite

HARVARD Citation

    Lee, A. et al. (2022). Impact of obesity on safety outcomes and treatment modifications with ado-trastuzumab emtansine in breast cancer patients. Journal of oncology pharmacy practice. pp. 49-54. [Online]. 
  
Back to record